Idiopathic pulmonary fibrosis (IPF) is an uncommon, yet deadly respiratory disease, characterized by a progressive decline in pulmonary function…
Articles by Patrícia Silva, PhD
The U.S. Food and Drug Administration has granted APD811, an investigational drug candidate internally developed by Arena Pharmaceuticals, orphan…
The American College of Chest Physicians’ (CHEST) series of guidelines for the management and treatment of pulmonary arterial…
The Pulmonary Hypertension Association (PHA) is hosting a webinar about the health value of exercise for…
The Pulmonary Hypertension Association (PHA) is organizing another edition of the annual educational forum “PHA On the…
Dr. Francisco Boin of the Scleroderma Center at The Johns Hopkins University School of Medicine is organizing a live…
A recent blog article entitled, “How High Is too High – Altitude and PAH” from pulmonology specialist Jeremy P. Feldman, published…
The Pulmonary Hypertension Association (PHA) recently nominated Stephen L. White as Chair of the Board of Trustees of the…
The Pulmonary Hypertension Association (PHA) has granted 13 awards to projects led by committed community activists for…
Cambridge University professor Nicholas Morrell, a leading researcher specializing in the study of heart disease, was recently awarded a …
SteadyMed Therapeutics, a pharmaceutical company focused on developing drugs to treat underserved medical needs in orphan and high value disease states, recently…
Yoga for PH is a novel exercise program developed by Henry Ford Hospital to improve balance, strength, reduce stress and…